healthcare

Amazon’s top healthcare executive, Neil Lindsay, is stepping down. He will be succeeded by Dr. Roy Schoenberg, co-founder of Amwell. This leadership change signals a strategic shift for Amazon’s healthcare division, suggesting a renewed focus on technological innovation and deep healthcare sector expertise to drive future growth.

Whoop is launching AI-powered health services, offering U.S. users on-demand access to licensed clinicians for consultations. This expansion, building on their biometric data, aims to provide real-time medical guidance alongside new AI-driven wellness features. The move follows significant funding and positions Whoop as a holistic health hub, integrating health records and personalized coaching.

Amazon is entering the weight-loss market with a new GLP-1 medication program via Amazon One Medical and Amazon Pharmacy. This initiative offers integrated virtual/in-person care, transparent pricing, and aims for same-day delivery in thousands of cities by 2026. Amazon’s move leverages its logistics and e-commerce expertise to disrupt chronic condition management and increase patient adherence.

The White House launched a new app showcasing President Trump’s second-term achievements and favorable news, featuring updates “straight from the source.” It highlights policy priorities, economic affordability data, and healthcare cost reductions, though data presentation is selective. The app also includes a feature for submitting tips to ICE and omits rising prices of certain goods and oil. Claims of live streaming capabilities are also questionable.

University of Hertfordshire researchers have developed an AI forecasting model for the NHS, leveraging historical data and machine learning to predict healthcare demand. This system analyzes patient trends, workforce availability, and demographics to improve resource allocation, staffing, and patient care strategies. Focusing on system-wide operations, the model aims to shift healthcare management from reactive to proactive, enhancing efficiency and informing crucial strategic decisions. The project is ongoing and expanding its pilot testing to various healthcare settings.

Humana is implementing Google Cloud’s AI, including Gemini Enterprise for CX, with its new Agent Assist tool. This initiative aims to empower member advocates by providing real-time conversation summaries, anticipating needs, and swiftly retrieving information. The goal is to enhance support speed, personalization, and accuracy while maintaining a human-centered approach where AI acts as a co-pilot. This aims to reduce administrative burdens and improve member welfare.

Horizon1000, a Gates Foundation and OpenAI initiative, aims to integrate AI into primary healthcare clinics across Africa, starting in Rwanda, with a $50 million investment to reach 1,000 clinics by 2028. The project focuses on alleviating administrative burdens for healthcare workers, not on advanced diagnostics. This effort addresses declining international aid for health and rising child mortality by using AI to streamline patient intake, record-keeping, and guidance, thereby improving access to quality care in resource-constrained settings.

Nvidia CEO Jensen Huang believes AI will create more jobs than it displaces, viewing it as a transformative “platform shift” like personal computing or the internet. He outlined a five-layer AI architecture from energy to applications. Huang argued that AI’s efficiency gains will boost overall demand for goods and services, leading to increased hiring, citing radiology and nursing as examples where AI frees up professionals for more critical patient care. Despite high demand, he doesn’t see an immediate AI investment bubble, as supply is struggling to keep up.

OpenEvidence, an AI startup for physicians, has raised $250 million at a $12 billion valuation, bringing its total funding to $700 million in under a year. The platform, trained on medical literature, aims to assist doctors in clinical decision-making. It claims over 40% adoption among US physicians and generates revenue through advertising. Despite competition from giants like OpenAI and Anthropic, OpenEvidence leverages its specialized focus and user data as competitive advantages. The founder aims for long-term independent growth, viewing potential IPOs from other AI leaders as paving the way for future public offerings.